Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac
and Pericardial Symptoms)

C 2011

Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

SVOBODA, Marek

Základní údaje

Originální název

Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

Název česky

Maligní perikardiální výpotek a srdeční tamponáda. (Kardiální a perikardiální symptomy)

Autoři

SVOBODA, Marek

Vydání

1. vyd. New York, The MASCC Textbook of Cancer Supportive Care and Survivorship, od s. 83-92, 10 s. 1. 2011

Nakladatel

Springer

Další údaje

Jazyk

angličtina

Typ výsledku

Kapitola resp. kapitoly v odborné knize

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/11:00051798

Organizační jednotka

Lékařská fakulta

ISBN

978-1-4419-1224-4

Klíčová slova česky

zhoubné nádory;paliativní léčba;rehabilitace;přežívání

Klíčová slova anglicky

cancer; palliation; rehabilitation; survivorship

Příznaky

Recenzováno

Změněno: 15. 4. 2012 11:33, Mgr. Michal Petr

Anotace

ORIG CZ

V originále

A malignant pericardial effusion and a cardiac tamponade are known life-threatening complications in cancer patients. An early recognition and a prompt treatment may dramatically relieve patients of symptoms and decrease a short-term risk of death from the effusion. Although the pericardial involvement by malignancy is the leading cause, other etiological factors need exclusion before the final treatment strategy is determined. The treatment of malignant pericardial effusions must be individualized with a consideration given to the patient’s condition and tumor type, the success rates and risks of the various treatment modalities, and their local availability and expertise. The initial relief of symptoms is achieved, in most cases, with a percutaneous pericardiocentesis. A subsequent drainage of the pericardial effusion with an indwelling catheter and a local sclerotherapy and/or chemotherapy alleviates the effusion without recurrence in most of the patients. These procedures are associated with low morbidity and mortality and are preferred in the initial management of symptomatic malignant pericardial effusions. Recommended therapy for a recurrent pericardial effusion include: a repetition of pericardiocentesis and intrapericardial instillation of agents with both sclerosing and cytostatic activity, a percutaneous balloon pericardiotomy, or a surgical treatment.

Česky

Kapitola popisuje diagnostiku a léčbu maligního perikardiálního výpotku.

Citovat

SVOBODA, Marek. Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms). In The MASCC Textbook of Cancer Supportive Care and Survivorship. 1. vyd. New York: Springer, 2011, s. 83-92. 1. ISBN 978-1-4419-1224-4.

@inbook{923235,
   author = {Svoboda, Marek},
   address = {New York},
   booktitle = {The MASCC Textbook of Cancer Supportive Care and Survivorship},
   edition = {1.},
   keywords = {cancer; palliation; rehabilitation; survivorship},
   language = {eng},
   location = {New York},
   isbn = {978-1-4419-1224-4},
   pages = {83-92},
   publisher = {Springer},
   title = {Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)},
   url = {http://www.springer.com/medicine/oncology/book/978-1-4419-1224-4},
   year = {2011}
}

TY  - CHAP
ID  - 923235
AU  - Svoboda, Marek
PY  - 2011
TI  - Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)
VL  - 1.
PB  - Springer
CY  - New York
SN  - 9781441912244
KW  - cancer
KW  - palliation
KW  - rehabilitation
KW  - survivorship
UR  - http://www.springer.com/medicine/oncology/book/978-1-4419-1224-4
N2  - A malignant pericardial effusion and a cardiac tamponade are known life-threatening complications in cancer patients. An early recognition and a prompt treatment may dramatically relieve patients of symptoms and decrease a short-term risk of death from the effusion. Although the pericardial involvement by malignancy is the leading cause, other etiological factors need exclusion before the final treatment strategy is determined. The treatment of malignant pericardial effusions must be individualized with a consideration given to the patient’s condition and tumor type, the success rates and risks of the various treatment modalities, and their local availability and expertise. The initial relief of symptoms is achieved, in most cases, with a percutaneous pericardiocentesis. A subsequent drainage of the pericardial effusion with an indwelling catheter and a local sclerotherapy and/or chemotherapy alleviates the effusion without recurrence in most of the patients. These procedures are associated with low morbidity and mortality and are preferred in the initial management of symptomatic malignant pericardial effusions. Recommended therapy for a recurrent pericardial effusion include: a repetition of pericardiocentesis and intrapericardial instillation of agents with both sclerosing and cytostatic activity, a percutaneous balloon pericardiotomy, or a surgical treatment.
ER  -

SVOBODA, Marek. Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms). In \textit{The MASCC Textbook of Cancer Supportive Care and Survivorship}. 1. vyd. New York: Springer, 2011, s.~83-92. 1. ISBN~978-1-4419-1224-4.

Přehled o publikaci